Cargando…

Quaternary and beyond cytoreduction: An updated and expanded analysis

OBJECTIVE: We sought to describe the clinicopathologic features and outcomes of patients undergoing quaternary, quinary, or senary cytoreductive surgery for ovarian cancer. METHODS: We retrospectively identified patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manning-Geist, Beryl L., Chi, Dennis S., Long Roche, Kara, Zivanovic, Oliver, Sonoda, Yukio, Gardner, Ginger J., O'Cearbhaill, Roisin E., Abu-Rustum, Nadeem R., Leitao, Mario M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405887/ https://www.ncbi.nlm.nih.gov/pubmed/34485661 http://dx.doi.org/10.1016/j.gore.2021.100851

Ejemplares similares

Assessment of wound perfusion with near-infrared angiography: A prospective feasibility study
por: Manning-Geist, Beryl L., et al.
Publicado: (2022)

Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery
por: Liu, Ying L., et al.
Publicado: (2019)

Primary osteosarcoma of the uterus with cardiac and pulmonary metastases
por: Abraham, Cynthia, et al.
Publicado: (2014)

Pattern of disease and response to pembrolizumab in recurrent cervical cancer
por: Miller, Kathryn M., et al.
Publicado: (2021)

Prevention over screening for ovarian cancer in patients with high-risk germline mutations: Misinterpreting the findings of ALDO
por: Manning-Geist, Beryl L., et al.
Publicado: (2023)

Gynecologic Survivorship Tool: Development, Implementation, and Symptom Outcomes
por: Carter, Jeanne, et al.
Publicado: (2022)

Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer
por: Gordhandas, Sushmita B., et al.
Publicado: (2022)

A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16(ecto) directed chimeric antigen receptors for recurrent ovarian cancer
por: Koneru, Mythili, et al.
Publicado: (2015)

Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission
por: Manning-Geist, Beryl L., et al.
Publicado: (2023)

Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis
por: Gordhandas, Sushmita, et al.
Publicado: (2022)

Immunotherapy for recurrent or metastatic vulvar carcinoma: A case report and review of current guidelines
por: Praiss, Aaron, et al.
Publicado: (2022)

Brain metastases in patients with low-grade endometrial carcinoma
por: Cybulska, Paulina, et al.
Publicado: (2018)

Quaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter?
por: Fotopoulou, C, et al.
Publicado: (2013)

Electronic patient-reported symptom monitoring in patients recovering from ambulatory minimally invasive gynecologic surgery: A prospective pilot study
por: Zivanovic, Oliver, et al.
Publicado: (2020)

Shared decision making for patients with breast and gynecologic malignancies undergoing chemotherapy associated with persistent alopecia
por: Freites-Martinez, Azael, et al.
Publicado: (2022)

The Yin and Yang of Cytoreductive SBRT in Oligometastases and Beyond
por: Onderdonk, Benjamin E., et al.
Publicado: (2019)

Dual targeting ovarian cancer by Muc16 CAR-T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1
por: Mun, Sung Soo, et al.
Publicado: (2023)

Society of Gynecologic Oncology Journal Club: Controversial conversations in Gynecologic cancer – The ABCs of ADCs (Antibody drug Conjugates)()
por: Martin, J., et al.
Publicado: (2023)

Quaternary history and contemporary patterns in a currently expanding species
por: Kerdelhué, Carole, et al.
Publicado: (2009)

Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer
por: Kyi, Chrisann, et al.
Publicado: (2021)

Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets
por: Friedman, Claire F., et al.
Publicado: (2023)

Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer
por: Navitski, Anastasia, et al.
Publicado: (2021)

Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas
por: Crowley, Fionnuala, et al.
Publicado: (2022)

Cost-effectiveness of hyperthermic intraperitoneal chemotherapy at primary cytoreduction of epithelial ovarian cancer based on residual disease status
por: Penn, Courtney A., et al.
Publicado: (2022)

2149: Primary management of advanced-stage ovarian cancer: 1 year at a high-volume care center
por: Byrne, Maureen, et al.
Publicado: (2018)

Simple and customizable method for fabrication of high-aspect ratio microneedle molds using low-cost 3D printing
por: Krieger, Kevin J., et al.
Publicado: (2019)

Metallic Microneedles for Transdermal Drug Delivery: Applications, Fabrication Techniques and the Effect of Geometrical Characteristics
por: Sargioti, Nikoletta, et al.
Publicado: (2022)

Corrigendum to “Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)” [Gynecol. Oncol. Rep. 31 (2020) 100532]
por: Santin, Alessandro D., et al.
Publicado: (2020)

A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission
por: O’Cearbhaill, Roisin E., et al.
Publicado: (2016)

Beyond BLASTing: Tertiary and Quaternary Structure Analysis Helps Identify Major Vault Proteins
por: Daly, Toni K., et al.
Publicado: (2013)

Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology
por: Bertoni, Martino, et al.
Publicado: (2017)

The Role of Predictive Biomarkers in Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists
por: Bosse, Tjalling, et al.
Publicado: (2021)

Combined immunotherapy and radiation for treatment of mucosal melanomas of the lower genital tract()
por: Schiavone, Maria B., et al.
Publicado: (2016)

Stereodivergent synthesis of vicinal quaternary-quaternary stereocenters and bioactive hyperolactones
por: Zheng, Haifeng, et al.
Publicado: (2018)

Cytoreductive surgery in ovarian cancer
por: Pomel, Christophe, et al.
Publicado: (2007)

Cytoreductive Nephrectomy in 2021: Obsolete
por: Meza, Luis, et al.
Publicado: (2021)

New Paradigms for Cytoreductive Nephrectomy
por: Lichtbroun, Benjamin J., et al.
Publicado: (2022)

ICU outcome of patients undergoing cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy: a single-center study
por: Nadeem, A, et al.
Publicado: (2015)

Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results
por: Hassan, Raffit, et al.
Publicado: (2023)

Stereospecific Construction of Quaternary Carbon Stereocenters from Quaternary Carbon Stereocenters
por: Patel, Kaushalendra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9ftjjvc235jb2ag3qslqb9kj5m